Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Acyclovir Dosing in Pregnancy for HSV

Treatment Recommendations by Clinical Scenario

  • The Centers for Disease Control and Prevention recommends oral acyclovir 400 mg three times daily for first clinical episodes of genital herpes in pregnant women 1, 2
  • For life-threatening HSV infections in pregnant women, such as disseminated infection, encephalitis, pneumonitis, or hepatitis, intravenous acyclovir is indicated with a standard dosing of 5 mg/kg every 8 hours until clinical resolution 1, 2

Safety Considerations

  • The Centers for Disease Control and Prevention states that the safety of systemic acyclovir in pregnant women has not been fully established, but registry findings do not indicate an increased risk for major birth defects compared to the general population 1, 2
  • The benefits of acyclovir may outweigh the risks in certain clinical scenarios, particularly for severe infections 1, 2

Common Pitfalls and Caveats

  • The Centers for Disease Control and Prevention notes that antiviral medications neither eradicate latent virus nor affect the risk, frequency, or severity of recurrences after discontinuation, and acyclovir resistance should be suspected if lesions persist during treatment 1, 2
  • The risk of HSV transmission to the neonate is highest among women who acquire genital herpes near the time of delivery (30%-50%) and lower among women with recurrent herpes (≤3%) 1, 2

Monitoring

  • The Centers for Disease Control and Prevention recommends that at the onset of labor, all women should be examined and questioned regarding symptoms of genital herpes, and viral cultures during pregnancy do not predict viral shedding at delivery and are not routinely indicated 2